E
Edge Animal Health
Biotechnology solutions advancing veterinary care with gene-engineered vaccines to enhance animal health and reduce antibiotic use
About Edge Animal Health
Edge Animal Health leverages state-of-the-art biotechnology tools to translate human disease treatments into veterinary applications. The company focuses on developing gene-engineered vaccines aimed at improving farm animal health and minimizing antibiotic dependency. Edge Animal Health operates in the veterinary medicine market, serving clients in the animal health industry, including farms and veterinary practices. The business model centers around research and development of advanced veterinary products, generating revenue through the commercialization of these biotechnological solutions. Led by Dr. Haven, a seasoned expert with extensive experience in the animal health sector, the company is committed to providing animals with a standard of care comparable to humans. Edge Animal Health values diversity and collaboration, seeking partnerships and talent that align with its mission to create a better future for animals.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 16.7/100
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEEDOther financing | Mar 2022 | $10M | $40M | Anterra Capital | — |
| EARLY VCOther financing | Mar 2020 | $0 | — | Anterra Capital | — |
Growth signals
Latest recorded traffic for Edge Animal Health is 1.1K monthly website visits, up 478.9% over the last three months.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Edge Animal Health in the Mount Pleasant ecosystem
The Edge Animal Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Anterra Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Edge Animal Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Edge Animal Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.